Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Buscopan

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
BACKGROUND Hyoscine N-butyl bromide (HBB) acts by inhibiting cholinergic transmission in the abdomino-pelvic parasympathetic… Expand
  • table 1
  • table 2
Highly Cited
2006
Highly Cited
2006
PurposeThe aim of this study was to determine the validity of the hepatic apparent diffusion coefficient (ADC) measurement. The… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
Highly Cited
2005
Highly Cited
2005
Objective:  To evaluate the efficacy and safety of hyoscine‐N‐butyl bromide (Buscopan) suppositories in the active phase of… Expand
Highly Cited
2003
Highly Cited
2003
The aim of this study was to examine the efficacy of IV Buscopan as a muscle relaxant in CT colonography in terms of colonic… Expand
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 4
2003
2003
AIM To evaluate the efficacy of peppermint oil in barium as a spasmolytic agent during a double-contrast barium enema (DCBE… Expand
Highly Cited
1995
Highly Cited
1995
PURPOSE To compare the spasmolytic effect of glucagon and buscopan in double contrast barium enema examination. PATIENTS AND… Expand
Highly Cited
1991
Highly Cited
1991
The analgesic and spasmolytic effects of dipyrone (Novalgin) (2500 mg/100 kg bodyweight) hyoscine-N-butylbromide (Buscopan) (20… Expand
1990
1990
A double-blind, randomized parallel group trial comparison involving 712 patients with irritable bowel syndrome was performed… Expand
1987
1987
We were interested to read the report by Thomas et al (1986) describing what was almost certainly a reaction to Buscopan… Expand
1977
1977
Detection of oesophageal varices is important in the diagnosis of portal hypertension. We have, therefore, compared the results… Expand